Current Atherosclerosis Reports-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2201186, encodeId=1d7c220118625, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：血管外科;非约稿综述;主动脉瘤 经验分享：自投综述，在编辑手里拖了三个多月，审稿人审了一个月左右接收 Submission is in publishing and rights 24 Apr 2024 Peer review Submission accepted 24 Apr 2024 Submission under peer review 22 Mar 2024 Submission passed technical check 22 Mar 2024 Revision received 21 Mar 2024 Submission under peer review 05 Dec 2023 Technical check Submission status Date Submission passed technical check 05 Dec 2023 Submission is under technical check 04 Dec 2023 Submission received Submission status Date Submission received 04 Dec 2023 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70ac6575208, createdName=ms9000001429548900, createdTime=Tue Apr 30 08:39:45 CST 2024, time=2024-04-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1250243, encodeId=ecaf125024347, content=综述都是约稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e95d2111381, createdName=若曦jennifer, createdTime=Sat Sep 17 13:14:34 CST 2022, time=2022-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101437, encodeId=30d6110143e70, content=上传文章有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101438, encodeId=8ede110143857, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538978, encodeId=8b7e5389e873, content=过去不错的，现在这么跌下去，很吓人。明年想再回到3分水平，也许真心太难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med_wu, createdTime=Tue Jul 18 18:23:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492616, encodeId=d6604926164d, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=445, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=)]

2024-04-30 ms9000001429548900 来自北京

审稿速度:6.0 | 投稿命中率:75.0
偏重的研究方向：血管外科;非约稿综述;主动脉瘤
经验分享：自投综述，在编辑手里拖了三个多月，审稿人审了一个月左右接收
Submission is in publishing and rights
24 Apr 2024
Peer review
Submission accepted
24 Apr 2024
Submission under peer review
22 Mar 2024
Submission passed technical check
22 Mar 2024
Revision received
21 Mar 2024
Submission under peer review
05 Dec 2023
Technical check
Submission status Date
Submission passed technical check
05 Dec 2023
Submission is under technical check
04 Dec 2023
Submission received
Submission status Date
Submission received
04 Dec 2023

56 0

[GetPortalCommentsPageByObjectIdResponse(id=2201186, encodeId=1d7c220118625, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：血管外科;非约稿综述;主动脉瘤 经验分享：自投综述，在编辑手里拖了三个多月，审稿人审了一个月左右接收 Submission is in publishing and rights 24 Apr 2024 Peer review Submission accepted 24 Apr 2024 Submission under peer review 22 Mar 2024 Submission passed technical check 22 Mar 2024 Revision received 21 Mar 2024 Submission under peer review 05 Dec 2023 Technical check Submission status Date Submission passed technical check 05 Dec 2023 Submission is under technical check 04 Dec 2023 Submission received Submission status Date Submission received 04 Dec 2023 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70ac6575208, createdName=ms9000001429548900, createdTime=Tue Apr 30 08:39:45 CST 2024, time=2024-04-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1250243, encodeId=ecaf125024347, content=综述都是约稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e95d2111381, createdName=若曦jennifer, createdTime=Sat Sep 17 13:14:34 CST 2022, time=2022-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101437, encodeId=30d6110143e70, content=上传文章有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101438, encodeId=8ede110143857, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538978, encodeId=8b7e5389e873, content=过去不错的，现在这么跌下去，很吓人。明年想再回到3分水平，也许真心太难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med_wu, createdTime=Tue Jul 18 18:23:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492616, encodeId=d6604926164d, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=445, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=)]

2022-09-17 若曦jennifer

综述都是约稿吗？

88 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2201186, encodeId=1d7c220118625, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：血管外科;非约稿综述;主动脉瘤 经验分享：自投综述，在编辑手里拖了三个多月，审稿人审了一个月左右接收 Submission is in publishing and rights 24 Apr 2024 Peer review Submission accepted 24 Apr 2024 Submission under peer review 22 Mar 2024 Submission passed technical check 22 Mar 2024 Revision received 21 Mar 2024 Submission under peer review 05 Dec 2023 Technical check Submission status Date Submission passed technical check 05 Dec 2023 Submission is under technical check 04 Dec 2023 Submission received Submission status Date Submission received 04 Dec 2023 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70ac6575208, createdName=ms9000001429548900, createdTime=Tue Apr 30 08:39:45 CST 2024, time=2024-04-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1250243, encodeId=ecaf125024347, content=综述都是约稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e95d2111381, createdName=若曦jennifer, createdTime=Sat Sep 17 13:14:34 CST 2022, time=2022-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101437, encodeId=30d6110143e70, content=上传文章有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101438, encodeId=8ede110143857, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538978, encodeId=8b7e5389e873, content=过去不错的，现在这么跌下去，很吓人。明年想再回到3分水平，也许真心太难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med_wu, createdTime=Tue Jul 18 18:23:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492616, encodeId=d6604926164d, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=445, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=)]

2021-12-28 Mia

上传文章有什么要求？

90 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2201186, encodeId=1d7c220118625, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：血管外科;非约稿综述;主动脉瘤 经验分享：自投综述，在编辑手里拖了三个多月，审稿人审了一个月左右接收 Submission is in publishing and rights 24 Apr 2024 Peer review Submission accepted 24 Apr 2024 Submission under peer review 22 Mar 2024 Submission passed technical check 22 Mar 2024 Revision received 21 Mar 2024 Submission under peer review 05 Dec 2023 Technical check Submission status Date Submission passed technical check 05 Dec 2023 Submission is under technical check 04 Dec 2023 Submission received Submission status Date Submission received 04 Dec 2023 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70ac6575208, createdName=ms9000001429548900, createdTime=Tue Apr 30 08:39:45 CST 2024, time=2024-04-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1250243, encodeId=ecaf125024347, content=综述都是约稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e95d2111381, createdName=若曦jennifer, createdTime=Sat Sep 17 13:14:34 CST 2022, time=2022-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101437, encodeId=30d6110143e70, content=上传文章有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101438, encodeId=8ede110143857, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538978, encodeId=8b7e5389e873, content=过去不错的，现在这么跌下去，很吓人。明年想再回到3分水平，也许真心太难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med_wu, createdTime=Tue Jul 18 18:23:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492616, encodeId=d6604926164d, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=445, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=)]

2021-12-28 rayms

如何判断两种药物之间是协同作用还是相加作用？

103 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2201186, encodeId=1d7c220118625, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：血管外科;非约稿综述;主动脉瘤 经验分享：自投综述，在编辑手里拖了三个多月，审稿人审了一个月左右接收 Submission is in publishing and rights 24 Apr 2024 Peer review Submission accepted 24 Apr 2024 Submission under peer review 22 Mar 2024 Submission passed technical check 22 Mar 2024 Revision received 21 Mar 2024 Submission under peer review 05 Dec 2023 Technical check Submission status Date Submission passed technical check 05 Dec 2023 Submission is under technical check 04 Dec 2023 Submission received Submission status Date Submission received 04 Dec 2023 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70ac6575208, createdName=ms9000001429548900, createdTime=Tue Apr 30 08:39:45 CST 2024, time=2024-04-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1250243, encodeId=ecaf125024347, content=综述都是约稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e95d2111381, createdName=若曦jennifer, createdTime=Sat Sep 17 13:14:34 CST 2022, time=2022-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101437, encodeId=30d6110143e70, content=上传文章有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101438, encodeId=8ede110143857, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538978, encodeId=8b7e5389e873, content=过去不错的，现在这么跌下去，很吓人。明年想再回到3分水平，也许真心太难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med_wu, createdTime=Tue Jul 18 18:23:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492616, encodeId=d6604926164d, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=445, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=)]

2017-07-18 med_wu

过去不错的，现在这么跌下去，很吓人。明年想再回到3分水平，也许真心太难。

392 0

[GetPortalCommentsPageByObjectIdResponse(id=2201186, encodeId=1d7c220118625, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：血管外科;非约稿综述;主动脉瘤 经验分享：自投综述，在编辑手里拖了三个多月，审稿人审了一个月左右接收 Submission is in publishing and rights 24 Apr 2024 Peer review Submission accepted 24 Apr 2024 Submission under peer review 22 Mar 2024 Submission passed technical check 22 Mar 2024 Revision received 21 Mar 2024 Submission under peer review 05 Dec 2023 Technical check Submission status Date Submission passed technical check 05 Dec 2023 Submission is under technical check 04 Dec 2023 Submission received Submission status Date Submission received 04 Dec 2023 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70ac6575208, createdName=ms9000001429548900, createdTime=Tue Apr 30 08:39:45 CST 2024, time=2024-04-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1250243, encodeId=ecaf125024347, content=综述都是约稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e95d2111381, createdName=若曦jennifer, createdTime=Sat Sep 17 13:14:34 CST 2022, time=2022-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101437, encodeId=30d6110143e70, content=上传文章有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101438, encodeId=8ede110143857, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538978, encodeId=8b7e5389e873, content=过去不错的，现在这么跌下去，很吓人。明年想再回到3分水平，也许真心太难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med_wu, createdTime=Tue Jul 18 18:23:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492616, encodeId=d6604926164d, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=445, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=)]

2012-11-28 qupeter

明年能不能冲到3分？大家谈谈

445 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务